Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Stanic, Karmen"'
Publikováno v:
Radiology and Oncology, Vol 57, Iss 3, Pp 389-396 (2023)
Stereotactic body radiation therapy (SBRT) precisely and non-invasively delivers ablative radiation dose to tumors in early-stage lung cancer patients who are not candidates for surgery or refuse it. The aim of research was to evaluate local control,
Externí odkaz:
https://doaj.org/article/0bdcf920cefb474fbabedb2cce985e22
Autor:
Vrankar Martina, Stanic Karmen, Jelercic Stasa, Ciric Eva, Vodusek Ana Lina, But-Hadzic Jasna
Publikováno v:
Radiology and Oncology, Vol 55, Iss 4, Pp 482-490 (2021)
Chemoradiotherapy (ChT-RT) followed by 12-month durvalumab is the new standard treatment for unresectable stage III non-small cell lung cancer. Survival data for patients from everyday routine clinical practice is scarce, as well as potential impact
Externí odkaz:
https://doaj.org/article/ae2e857754654969af9f34a239d8657f
Autor:
Zemanova Milada, Jakopovic Marko, Stanic Karmen, Łazar-Poniatowska Małgorzata, Vrankar Martina, Rusu Petronela, Ciuleanu Tudor, Radosavljevic Davorin, Bogos Krisztina, Nawrocki Sergiusz
Publikováno v:
Radiology and Oncology, Vol 54, Iss 4, Pp 447-454 (2020)
The aim of this project was to collect real-world evidence and describe treatment patterns for stage III non-small cell lung cancer in Central and Eastern Europe. Based on real-world evidence, an expert opinion was developed, and the unmet needs and
Externí odkaz:
https://doaj.org/article/4308dbb0da68481db644aa4b25de9de1
Publikováno v:
Radiology and Oncology, Vol 54, Iss 3, Pp 353-363 (2020)
Consolidation radiotherapy (cRT) in extended disease small cell lung cancer (ED-SCLC) showed improved 2-year overall survival in patients who responded to chemotherapy (ChT) in CREST trial, however results of two meta - analysis were contradictive. R
Externí odkaz:
https://doaj.org/article/4f58fb909c764efd851b9746c9362db6
Publikováno v:
Radiology and Oncology, Vol 53, Iss 4, Pp 453-458 (2019)
The 8th edition of tumor node metastasis (TNM) staging system for lung cancer introduced a revision of M descriptor. The limitation of new classification to predict prognosis is its focus on anatomical extent of the disease only. Information on molec
Externí odkaz:
https://doaj.org/article/88ff54cc9ccd43ea9f39f97e0d04a9ce
Autor:
Marinko Tanja, Stanic Karmen
Publikováno v:
Radiology and Oncology, Vol 52, Iss 3, Pp 275-280 (2018)
Postmastectomy radiotherapy (PMRT) improves survival by eliminating potential occult lesions in the chest wall and lymphatic drainage area. Meta-analysis has shown that PMRT reduces mortality and local recurrence of patients with node positive breast
Externí odkaz:
https://doaj.org/article/ef5e60d9168147f09ff89372187dbfa5
Autor:
Vrankar Martina, Stanic Karmen
Publikováno v:
Radiology and Oncology, Vol 52, Iss 3, Pp 281-288 (2018)
Standard treatment for patients with inoperable locally advanced non-small cell lung cancer (NSCLC) is concurrent chemoradiotherapy (CCRT). Five-year overall survival rates range between 15 and 25%, while long term survival data are rarely reported.
Externí odkaz:
https://doaj.org/article/79c3ebdd5922436897cb086b37edb296
Autor:
Hitij, Nina Turnšek 1, ∗, Kern, Izidor 1, Sadikov, Aleksander 2, Knez, Lea 1, Stanič, Karmen 3, Zwitter, Matjaž 3, Cufer, Tanja 1, 4
Publikováno v:
In Clinical Lung Cancer May 2017 18(3):e187-e196
Autor:
Zwitter Matjaz, Stanic Karmen, Rajer Mirjana, Kern Izidor, Vrankar Martina, Edelbaher Natalija, Kovac Viljem
Publikováno v:
Radiology and Oncology, Vol 48, Iss 4, Pp 361-368 (2014)
Background. Pharmaco-dynamic separation of cytotoxic and targeted drugs might avoid their mutual antagonistic effect in the treatment of advanced non-small cell lung cancer (NSCLC).
Externí odkaz:
https://doaj.org/article/267179c7a6be482883af906442aa3b24
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.